ALIGOS THERAPEUTICS INC

Capabilities

Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded with the mission to improve patient outcomes by developing best-in-class therapies for the treatment of liver and viral diseases. Aligos applies its science driven approach and deep R&D expertise to advance its purpose-built pipeline of therapeutics for diseases with high unmet medical need such as chronic hepatitis B infection (CHB), metabolic dysfunction-associated steatohepatitis (MASH), and coronaviruses.